help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 62, No. 3 479-483
doi:10.1210/jcem-62-3-479
Copyright © 1986 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RASMUSSEN, D. D.
Right arrow Articles by YEN, S. S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RASMUSSEN, D. D.
Right arrow Articles by YEN, S. S. C.

Gonadotropin-Releasing Hormone Neurosecretion in the Human Hypothalamus: In Vitro Regulation by Dopamine*

DENNIS D. RASMUSSEN, JAMES H. LIU, PAUL L. WOLF and SAMUEL S. C. YEN

Departments of Reproductive Medicine and Pathology La Jolla, California 92093
University of California, San Diego La Jolla, California 92093

Address requests for reprints to: Dennis Rasmussen, Ph,D., Department of Reproductive Medicine T-002, University of California, San Diego, La Jolla, California 92093.

An in vitro perifusion system was used to investigate GnRH release from adult human hypothalami in response to dopamine (DA) and the DA receptor antagonist haloperidol (HAL). Administration of a 1-µM pulse of DA consistently elicited a mean ± SE 218 ± 59%increase(P < 0.05; n = 5) in GnRH release, whereas 1 µM HAL had no effect. Administration of 1 µM DA during three perifusions in which 1 µM HAL was added to the medium failedto alter basal GnRH release. Incontrast, DA did evoke an acute 98 ± 39% increase (P < 0.06) in GnRH release during threematching perifusions with medium containing the {alpha}-adrenergic antagonist phentolamine. These studies demonstrate that DA can stimulate in vitro release of GnRH from the adult human hypothalamus by a DA receptormediated mechanism.

* This work was supported in part by a Mellon Foundation Faculty Scholar Award (to D.D.R.)and NIH Grant HD-12303, and was conducted in part by the Clayton Foundation for Research, California Division (S.S.C.Y).

Received September 6, 1985.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. Barnes and R. L. Rosenfield
The Polycystic Ovary Syndrome: Pathogenesis and Treatment
Ann Intern Med, March 1, 1989; 110(5): 386 - 399.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society